Description
IGF::OT::IGF, BLOOD AND BLOOD PRODUCTS
First action · last action
2015-03-25 · 2017-06-14
Transactions
2
First transaction's obligation
$630,876
Base + all options value (sum of deltas)
$453,539
Extent competed
COMPETED UNDER SAP
Other than full & open authority
—
Set-aside
NO SET ASIDE USED.
Offers received
1
SDVOSB flag on record
No
NAICS
325413 · IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING
Modification chain · 2 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2015-03-25+$630,876= $630,876
- Mod P000012017-06-14-$177,337= $453,539
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2015-03-25 | +$630,876 | $630,876 | IGF::OT::IGF, BLOOD AND BLOOD PRODUCTS |
| Mod P00001· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2017-06-14 | −$177,337 | $453,539 | IGF::OT::IGF, BLOOD AND BLOOD PRODUCTS |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI HJD6G4D6TJY5)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C26126P1095 | 261-NETWORK CONTRACT OFFICE 21 (36C261) · AN12 · HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH | $39,172 | FY2026 |
| 36C24E26N0092 | RPO EAST (36C24E) · Q301 · REFERENCE LABORATORY TESTING | $8,136,000 | FY2026 |
| 36C26126D0025 | 261-NETWORK CONTRACT OFFICE 21 (36C261) · 6506 · BLOOD AND BLOOD PRODUCTS | $0 | FY2026 |
| 36C26126N0339 | 261-NETWORK CONTRACT OFFICE 21 (36C261) · 6506 · BLOOD AND BLOOD PRODUCTS | $400,000 | FY2026 |
| 36C26126C0001 | 261-NETWORK CONTRACT OFFICE 21 (36C261) · H199 · QUALITY CONTROL- MISCELLANEOUS | $263,280 | FY2026 |
| 36C26126C0003 | 261-NETWORK CONTRACT OFFICE 21 (36C261) · Q505 · MEDICAL- GASTROENTEROLOGY | $411,668 | FY2026 |
Other recipients under Q515 from 261-NETWORK CONTRACT OFFICE 21 (36C261) (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| 36C26126P0773 | STANFORD HEALTH CARE | 261-NETWORK CONTRACT OFFICE 21 (36C261) | $51,660 | FY2026 |
| 36C26126N0521 | PENINSULA HISTOPATHOLOGY LABORATORY INC | 261-NETWORK CONTRACT OFFICE 21 (36C261) | $706,848 | FY2026 |
| 36C26126F0277 | TITAN-AUXO, LLC | 261-NETWORK CONTRACT OFFICE 21 (36C261) | $724,041 | FY2026 |
| 36C26126N0176 | GLENOAKS PATHOLOGY MEDICAL GROUP INC | 261-NETWORK CONTRACT OFFICE 21 (36C261) | $124,758 | FY2026 |
| 36C26126P0295 | MISCELLANEOUS FOREIGN AWARDEES | 261-NETWORK CONTRACT OFFICE 21 (36C261) | $8,221 | FY2026 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA26115P1434_3600_-NONE-_-NONE- · retrieved 2026-09-26.